Xeroform Dressing Application: Nursing Steps & Safety | NurseOnShift
🩹 Wound care — non-adherent contact layer

Xeroform Dressing Application: Petrolatum Contact Layer at the Bedside

On graft donor sites and shallow healing wounds, the yellow gauze is meant to protect tissue on removal—not to absorb a soaking pad by itself. Xeroform dressing application means pairing the contact layer with the right secondary cover, keeping exposure time short, and telling expected petrolatum staining from malodorous discharge that needs escalation.

14 min read
Updated 24 May 2026
Medically Reviewed

Quick facts

Product role
Non-adherent petrolatum contact layer
Must pair with
Absorbent secondary dressing for drainage
Time on task
About 15–25 min per dressing episode
Also known as
Petrolatum gauze; non-adherent dressing

Key takeaway

Xeroform protects the wound bed on removal—your clinical judgment is whether exudate still belongs under an absorbent secondary layer, and whether yellow staining is residue or cellulitis needing same-day review.

Quick procedure summary

Procedure nameXeroform dressing application
Also known asPetrolatum gauze; non-adherent dressing; bismuth tribromophenate contact layer
CategoryWound care — contact-layer dressing
Clinical purposeProtect the wound bed with a non-adherent layer that limits dressing trauma and supports moist wound healing under an absorbent cover
Who performsRegistered nurses and trained nursing associates per competency; tissue viability nurses advise on complex wounds
Estimated timeAbout 15–25 minutes including assessment, removal, application, and documentation (longer if irrigation or multiple sites)
Clinical settingsHospital wards, burns units, surgical wards, outpatient wound clinics, community nursing

What is Xeroform dressing application?

Xeroform is a yellow, petrolatum-impregnated gauze often used as a non-adherent contact layer between the wound bed and an outer absorbent dressing. Nurses apply it when the care plan calls for gentle coverage that reduces adherence to granulating or epithelialising tissue—common after skin graft harvest, on partial-thickness burns, and on shallow surgical or traumatic wounds with low-to-moderate exudate.

The skill is not “place yellow gauze and tape”—it is sizing the layer to the wound without stretching, pairing it with a secondary dressing matched to drainage, and reassessing the wound bed before you cover it. Principles align with Royal Marsden Manual — Dressing a wound and Chapter 18: Wound management on RMM Online. Licensed Marsden Nursing Procedure materials in the project library (Dressing a wound, Aseptic technique example: changing a wound dressing) informed scope alignment; proprietary step text and illustrations are not reproduced here.

Pair contact-layer skills with wound care for the full dressing-change workflow, wound measurement when trending size, and skin assessment for periwound integrity.

When Xeroform fits — and when it does not

Xeroform is a contact layer, not a complete dressing system. Use the wound bed, exudate level, and orders—not habit—to decide.

Clinical pictureOften appropriateUsually inappropriate without specialist review
Skin graft donor site; partial-thickness burn Non-adherent contact layer with absorbent secondary cover Contact layer alone on heavily draining burn without absorbent dressing
Shallow surgical or traumatic wound; low–moderate serous exudate Protects healing margins during dressing changes Cavity or tunnel wound needing packing rather than flat contact layer
Autolytic debridement under occlusive/absorbent cover (per plan) May be ordered as interface under secondary dressing Heavy slough requiring sharp debridement without medical plan
Heavy purulent exudate; suspected deep infection Only if care plan specifies contact layer plus appropriate absorbent system and escalation pathway Routine Xeroform without infection review, culture when indicated, or antibiotic plan

Institutional protocols may vary for product brands, sterile versus clean technique, and frequency of change.

Contact layer plus secondary dressing

Xeroform does not absorb large volumes of exudate. Nurses almost always add a secondary dressing (foam, abdominal pad, gauze bolster, or other absorbent layer per formulary) and secure with tape, bandage, or Montgomery straps when repeated changes are expected.

  • Low exudate: thin secondary layer; avoid macerating periwound skin with unnecessary moisture.
  • Increasing strike-through: reassess exudate and consider more absorbent secondary dressing or earlier review—not only a fresh Xeroform sheet.
  • Strike-through with odour or fever: treat as possible infection; do not attribute solely to “yellow staining” from the contact layer.

Xeroform versus other contact layers

Xeroform (petrolatum + bismuth tribromophenate gauze)

  • Yellow tint; leaves petrolatum residue on removal
  • Non-adherent interface for fragile healing tissue
  • Requires secondary absorbent dressing for drainage
  • Check allergy history to petrolatum or bismuth components

Plain petrolatum gauze / silicone contact layers

  • Similar non-adherent role without bismuth component
  • Product choice follows formulary and patient allergy profile
  • Still needs exudate-matched secondary dressing

Alginate / foam as primary layer

  • Absorb exudate directly—different role than thin contact layer
  • May adhere to granulation if used without interface on fragile beds
  • Follow tissue viability or surgical orders

Clinical indications

  • Care plan or prescriber orders a non-adherent petrolatum contact layer
  • Skin graft donor site or partial-thickness thermal injury per burn or surgical protocol
  • Shallow wounds with low-to-moderate exudate where minimizing dressing trauma is a priority
  • Interface under absorbent dressing during staged wound management
  • Transition from laceration care when deeper closure is complete and surface epithelialisation needs gentle coverage

Cautions and contraindications

  • Known allergy or sensitivity to petrolatum, bismuth tribromophenate, or dressing adhesives—use an alternative contact layer per formulary
  • Heavy exudate without adequate secondary absorption—risk of periwound maceration and infection
  • Deep cavity or sinus wound—may need wound packing or specialist plan, not flat contact gauze alone
  • Clinical infection requiring medical review—manage infection pathway before routine dressing change only
  • Active arterial insufficiency or unassessed leg ulcer—vascular and ulcer type assessment before compression or dressing regimen

When in doubt about wound type or dressing selection, involve tissue viability or the surgical team before repeating the same product.

Equipment checklist

Xeroform gauze (size appropriate to wound; institutional formulary)
Secondary absorbent dressing and fixation (tape, bandage, Montgomery straps per plan)
Sterile dressing pack, sterile gloves, and sterile field when aseptic technique required
Normal saline or ordered cleansing solution; gallipots or irrigation supplies if ordered
Clean dressing trolley; hand hygiene supplies; waste bags
Ruler or wound measurement guide if trending size; photography per policy
Analgesia available if dressing changes are painful

Patient preparation

  • Identify the patient with two identifiers; confirm wound site matches chart and care plan.
  • Review orders for contact layer type, cleanse solution, secondary dressing, and change frequency.
  • Allergy check including petrolatum, bismuth products, iodine, and adhesive tapes.
  • Explain the procedure; offer analgesia before painful sites (donor sites, burns).
  • Position to expose the wound while maintaining dignity and joint comfort.
  • Prepare new dressing on the sterile field before removing the soiled dressing to limit exposure time.

Pediatric note: Use distraction and parent involvement; avoid tension on fragile skin when securing.

Geriatric note: Loosen adhesives along the skin plane; float adherent contact layers with saline if needed to prevent skin tears.

Step-by-step Xeroform application

1

Hand hygiene and setup

Perform hand hygiene. Prepare the trolley: lower shelf for clean supplies, upper shelf for sterile field when required. Open outer packs using corners only.

2

Remove the outer dressing

Wear non-sterile gloves. Remove fixation and absorbent layers; place soiled material in waste below the sterile field. Discard gloves and perform hand hygiene.

3

Assess the wound bed

Describe tissue type, exudate, odour, and periwound skin. Note whether yellow residue is expected from prior contact layer versus new purulent drainage. Measure if ordered.

Sterility checkpoint: Confirm sterile gloves, field, and Xeroform remain uncontaminated before touching the wound bed.
4

Remove prior contact layer gently

Moisten adherent gauze with saline if needed; lift along the plane of the wound—do not pull perpendicular to fragile epithelium. If material is embedded or bleeding increases, stop and seek review.

5

Cleanse per orders

Irrigate or cleanse with ordered solution (commonly 0.9% saline). Avoid routine antiseptic pooling in granulating tissue unless prescribed. Pat dry periwound skin carefully.

6

Apply Xeroform

Cut or fold to cover the wound base and margins without tension. Lay flat—do not stretch the mesh. For linear wounds, one continuous piece may reduce gaps; institutional protocols may vary.

7

Add secondary dressing and secure

Apply absorbent layer matched to exudate. Secure without constricting circulation; protect joints and bony prominences. Label site if policy requires.

8

Dispose, comfort, and handoff

Dispose of waste in appropriate bags. Reposition for comfort. Perform hand hygiene. Update the patient on what to report before the next review.

Removal pitfalls nurses see at the bedside

  • Confusing yellow stain with infection: petrolatum and bismuth may tint residue or periwound skin—compare with odour, increasing pain, purulence, and systemic signs.
  • Dry removal on graft sites: increases pain and epithelial tear—moisten along the contact plane first when policy allows.
  • Stretching the mesh: narrows pores and can dig into wound edges—handle with forceps at edges only.
  • Skipping secondary dressing: leads to strike-through and maceration on draining wounds.

Post-procedure care and monitoring

  • Monitor outer dressing for strike-through, loosening, or patient tampering
  • Reinforce off-loading for plantar or heel wounds when ordered
  • Review glucose control and nutrition when type 2 diabetes affects healing
  • Schedule next dressing change per plan—not an arbitrary ward routine from another patient

Nursing documentation

  • Date, time, wound location, and wound bed description (tissue type, exudate, odour)
  • Contact layer documented (e.g. petrolatum/bismuth gauze) and secondary dressing type
  • Cleansing solution used; patient tolerance and analgesia given
  • Periwound skin condition; whether residue staining was present and expected
  • Notifications to medical or tissue viability teams; next review time

Common complications

  • Periwound maceration from inadequate absorption or infrequent changes
  • Contact dermatitis or allergy—erythema beyond wound margin after application
  • Trauma on removal—bleeding or denuded epithelium from dry pull
  • Delayed recognition of infection—attributed to “normal” yellow staining or odour
  • Prolonged use without reassessment—wound depth or exudate changes but dressing regimen unchanged

When to escalate

Increasing pain, purulent drainage, malodorous discharge, or spreading erythema—notify promptly; consider wound culture when results will change management
Fever or rigors with wound changes—sepsis screening per protocol
Bleeding that does not settle with gentle pressure
Exposed tendon, bone, or rapid wound enlargement
Allergy suspected after application—remove product and seek medical review

Clinical pearls

  • Cut Xeroform slightly larger than the wound bed so edges are covered without bunching in cavities.
  • Document “contact layer + secondary dressing”—auditors and the next nurse need both layers named.
  • On donor sites, coach patients that mild yellow staining on the outer pad can be expected; report soaking, odour, or fever.
  • When exudate increases, escalate the plan—do not stack more Xeroform sheets.

Patient education

Why a yellow contact layer is used and that it should not be removed at home unless community services trained them
Report strike-through, odour, fever, or increasing pain before the next scheduled visit
Protect fixation from friction and moisture; follow burn or surgical activity restrictions
For sun-related partial-thickness injury, link to sunburn prevention teaching when relevant

NCLEX practice questions

A saturated outer pad on a thigh donor site is not “normal yellow staining”—practise NCLEX-style clinical judgment practice for Xeroform dressing application: priority action when drainage and temperature change, select-all-that-apply safe contact-layer technique, post-dressing trend interpretation, and matrix escalation for infection versus expected residue (recognise cues → analyse exudate → prioritise review → act → evaluate outcomes on the next dressing round).

Unfolding case — burns/plastics ward. Ms. Okonkwo, 42, day 3 after split-thickness skin graft to the left lower leg; right anterior thigh is the donor site. Care plan: petrolatum contact layer with foam secondary dressing daily. At today’s change you note the foam is fully saturated, serous fluid mixed with yellow-green purulence at the donor margin, pain 6/10 (was 3/10), and temp 38.0 °C oral. She has type 2 diabetes.

Question 1 — Priority action

Which action should the nurse take first?

Question 2 — Select all that apply

Select all that apply — which actions support safe Xeroform application during a dressing change?

Question 3 — Trend interpretation

After antibiotics and dressing plan adjustment, the next donor-site review shows:

Trend snapshot
Outer foam: minimal strike-through
Exudate: serous only; no purulence
Pain: 2/10
Temp: 36.9 °C oral

Select all that apply — which nursing actions are appropriate now?

Question 4 — Matrix judgment

For each donor-site or contact-layer situation, select the best nursing action category (one per row).

Situation Continue routine monitoring / supportive care Notify clinician / urgent same-day pathway Activate rapid response / emergency escalation
Day 2 donor site: serous strike-through on foam, pain 2/10, afebrile, epithelialising bed per plan
New purulent drainage at margin, temp 38.2 °C, increasing pain after contact-layer change
Bleeding from donor bed after dry pull of adherent gauze; pressure not yet applied
Rigors, hypotension 84/48 mmHg, and rapidly spreading erythema from thigh donor site

On a small screen, swipe or scroll sideways to see the full table.

Answer key & rationale

Frequently Asked Questions

Is Xeroform the same as plain petrolatum gauze?

Xeroform includes bismuth tribromophenate in petrolatum-impregnated mesh, giving a yellow tint and antimicrobial properties attributed to the bismuth component in product labeling. Plain petrolatum gauze is a similar non-adherent contact layer without that additive. Follow formulary and allergy profile.

Can Xeroform be used without a second dressing?

On very low-exudate wounds some plans use a light cover, but most clinical scenarios require an absorbent secondary layer to manage drainage and protect periwound skin. Institutional protocols may vary.

Does yellow staining always mean infection?

No. Petrolatum and bismuth residue can stain dressings or periwound skin. Infection is suggested by increasing pain, purulence, malodour, spreading erythema, or systemic signs such as fever—not colour alone.

How often should Xeroform dressings be changed?

Frequency depends on wound type, exudate, and orders—from daily on some donor sites to less frequent when strike-through is minimal. Do not rely on a routine borrowed from another patient.

When should nurses use aseptic technique?

Use aseptic non-touch technique for open surgical wounds, graft sites, and when policy requires sterility. Some community chronic wounds may use clean technique per local standard—always follow your organisation’s wound-care policy.

How is this different from negative pressure wound therapy?

Negative pressure wound therapy uses sealed foam and suction. Xeroform is a passive contact layer under conventional absorbent dressings unless the team changes the plan.

References

  1. The Royal Marsden Manual of Clinical Nursing ProceduresDressing a wound (Action 18.1; RMM Online).
    https://www.rmmonline.co.uk/manual/c18-fea-0001
  2. Royal Marsden Manual — Chapter 18: Wound management — Overview.
    https://www.rmmonline.co.uk/manual/c18-sec-0004
  3. Royal Marsden Manual — Aseptic technique example: changing a wound dressing (Chapter 4).
    https://www.rmmonline.co.uk/manual/c04-fea-0014
  4. Royal Marsden Manual of Clinical Nursing ProceduresProcedures (RMM Online hub).
    https://www.rmmonline.co.uk/contents/procedures
  5. NICE. Pressure ulcers: prevention and management (NG179).
    https://www.nice.org.uk/guidance/ng179
  6. Centers for Disease Control and Prevention (CDC). Standard Precautions for All Patient Care.
    https://www.cdc.gov/infection-control/hcp/basics/standard-precautions.html
  7. NHS. Pressure ulcers (pressure sores).
    https://www.nhs.uk/conditions/pressure-sores/

Editorial standards & medical review

About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on practical bedside skills, patient safety, and clinical decision support for nurses.

Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, clarity, and alignment with current nursing standards for Xeroform dressing application.

Policies: Medical Review Process · Editorial Policy · Correction Policy